Phthalazine derivatives as inhibitors of protein kinase

Details Phthalazine derivatives as inhibitors of protein kinase Phthalazine derivatives as inhibitors of protein kinase

2007-11-14

2011-10-25

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S248000, C514S234500, C514S230500, C540S492000, C544S237000, C544S116000, C544S105000

Reexamination Certificate

active

08044041

ABSTRACT:
The present invention relates to novel phthalazine derivatives and, more particularly, to phthalazine derivatives of formula (III) that are useful as protein kinase inhibitors. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and methods of treatment using the compounds.

REFERENCES:
patent: 6589951 (2003-07-01), Napoletano et al.
patent: 6686347 (2004-02-01), Bold et al.
patent: 2006/0205743 (2006-09-01), Kataoku et al.
patent: 2007/0053910 (2007-03-01), Frigerio et al.
patent: 2009/0221599 (2009-09-01), Boyd et al.
patent: 2010/0204240 (2010-08-01), Aicher et al.
patent: WO 00/05218 (2000-02-01), None
patent: WO 2004/099177 (2004-11-01), None
patent: WO 2005/039506 (2005-05-01), None
patent: WO 2005/117909 (2005-12-01), None
patent: WO 2006/071819 (2006-07-01), None
patent: WO 2006/094187 (2006-09-01), None
Griesser, Chapter 8, The Importance of Solvates (pp. 211-230), Polymorphism: In the Pharmaceutical Industry, Hilfiker, 2006.
Britain, <http://www.netlibrary.com
lreader.dll?bookid=12783&filename=Page—126.html>, pp. 126-127, 2008.
Hackh's Chemical Dictionary, 3rdEd., 1944, p. 18, “acyl.”
Wikipedia, Acyl, last modified Mar. 11, 2010.
IUPAC http://www.iupac.org/goldbook/A00123.pdf, downloaded Oct. 29, 2010.
Hawley's Condensed Chem. Dict., 14th Ed., 2002.
International Search Report for PCT/US2007/084602, mailed Apr. 3, 2008.
Written Opinion of the International Searching Authority for PCT/US2007/084602, mailed Apr. 3, 2008.
Choi et al., Protein Kinsase Cδ-mediated Proteasonal Degradation of MAP Kinase Phosphatase-1 Contributes to Glutamate-induced Neuronal Cell Death, Journal of Cell Science 199, 1329-1340, 2006.
Inagaki et al., Cardioprotection by ε-Protein Kinase C Activation From Ischemia, Continous Delivery and Antiarrythmic Effect of an ε-Protein Kinase C-Activating Peptide,Circulation, 2005; 111:44-50.
Koya et al., Protein Kinase C Activation and the Development of Diabetic Complications, Diabetes, vol. 47, 859-866, Jun. 1998.
Piatnitski et al., Arylphthalazines: Identification of a New Phthalazine Chemotype as Inhibitors of VEGFR Kinase, Bioorganice & Medicinal Chemistry Letters 15 (2005) 4696-4698.
Street et al., Synthesis and Biological Evaluation of 3-Heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and Analogues as Subtype-Selective Inverse Agonists for the GABAAα5 Benzodiazepine Binding Site, J. Med. Chem 2004, 47, 3642-2657.
Tortora et al., Protein Kinase A Type I: A Target for Cancer Therapy, Clinical Cancer Research, vol. 8, 303-304, Feb. 2002.
Watanabe et al., 4-(3-Chloro-4-methoxybenzyl)aminophthalazines: Synthesis and Inhibitory Activity Toward Phosphodiesterase 5, J. Med. Chem. 2000, 43, 2523-2529.

Affiliated with

Also associated with

Rating

Phthalazine derivatives as inhibitors of protein kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phthalazine derivatives as inhibitors of protein kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phthalazine derivatives as inhibitors of protein kinase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4275929